🕵️ AYTU Biopharma, Inc ($AYTU)
SEC insider & ownership activity, last 12 months · CIK 1385818 · every row links its SEC filing
Insider buy value was withheld pending verification over the last 12 months. AWM Investment Company, Inc. trimmed 6.9% → 5.8%. No red-flag 8-Ks in the window.
Insider flow
1 buyer, value withheld pending verification (1 lots) · 1 seller, $1K (1 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Dockery Carl | 1 | value withheld pending verification | 1 | $1K | Dec 30, 2020 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Nantahala Capital Management, LLC | 14.4% | 13D | Jun 6, 2025 | filing ↗ | |
| Wilmot B. Harkey | 14.4% | 13D | Jun 6, 2025 | filing ↗ | |
| Mack Daniel | 14.4% | 13D | Jun 6, 2025 | filing ↗ | |
| Lytton-Kambara Foundation | 10.0% | 13G | Nov 14, 2025 | filing ↗ | |
| Stonepine Capital Management, LLC | 9.9% | 13G | Aug 13, 2025 | filing ↗ | |
| Stonepine Capital, L.P. | 9.9% | 13G | Aug 13, 2025 | filing ↗ | |
| Stonepine GP, LLC | 9.9% | 13G | Aug 13, 2025 | filing ↗ | |
| Jon M. Plexico | 9.9% | 13G | Aug 13, 2025 | filing ↗ | |
| AWM Investment Company, Inc. | 5.8% | 13G | Feb 13, 2026 | filing ↗ | |
| Laurence W. Lytton | 5.6% | 13G | Jun 13, 2025 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Agreement terminated (1.02) | Jun 23, 2026 | filing ↗ |
| Earnings (2.02) | May 13, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 13, 2026 | filing ↗ |
| Material agreement (1.01) | Mar 31, 2026 | filing ↗ |
| Earnings (2.02) | Mar 31, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Mar 31, 2026 | filing ↗ |
| Material Modifications to Rights of Security Holders (3.03) | Mar 31, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 31, 2026 | filing ↗ |
| Earnings (2.02) | Feb 3, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 3, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jan 20, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 20, 2026 | filing ↗ |
| Shareholder vote (5.07) | Dec 10, 2025 | filing ↗ |
| Earnings (2.02) | Nov 13, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 13, 2025 | filing ↗ |
| Earnings (2.02) | Sep 23, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 23, 2025 | filing ↗ |